LGM

Logos Global Management Portfolio holdings

AUM $749M
This Quarter Return
+27.42%
1 Year Return
+18.94%
3 Year Return
+431.72%
5 Year Return
+481.1%
10 Year Return
–
AUM
$855M
AUM Growth
+$855M
Cap. Flow
+$19.6M
Cap. Flow %
2.3%
Top 10 Hldgs %
52.05%
Holding
71
New
17
Increased
11
Reduced
9
Closed
23

Top Buys

1
BNTX icon
BioNTech
BNTX
$34.2M
2
INSM icon
Insmed
INSM
$31.1M
3
NBIX icon
Neurocrine Biosciences
NBIX
$27.3M
4
CYTK icon
Cytokinetics
CYTK
$23.5M
5
IDYA icon
IDEAYA Biosciences
IDYA
$23.1M

Top Sells

1
IRON icon
Disc Medicine
IRON
$46.6M
2
CLDX icon
Celldex Therapeutics
CLDX
$30.6M
3
IONS icon
Ionis Pharmaceuticals
IONS
$30M
4
GLPG icon
Galapagos
GLPG
$23M
5
COGT icon
Cogent Biosciences
COGT
$21.6M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IRON icon
26
Disc Medicine
IRON
$2.07B
$12.7M 1.48%
200,000
-735,000
-79% -$46.6M
SYRE icon
27
Spyre Therapeutics
SYRE
$996M
$11.6M 1.36%
500,000
+300,000
+150% +$6.98M
EWTX icon
28
Edgewise Therapeutics
EWTX
$1.51B
$10.7M 1.25%
400,000
-50,000
-11% -$1.34M
DYN icon
29
Dyne Therapeutics
DYN
$1.92B
$10.6M 1.24%
450,000
+290,000
+181% +$6.83M
PLRX icon
30
Pliant Therapeutics
PLRX
$101M
$9.88M 1.16%
+750,000
New +$9.88M
DRUG
31
Bright Minds Biosciences
DRUG
$276M
$8.82M 1.03%
+245,000
New +$8.82M
YMAB icon
32
Y-mAbs Therapeutics
YMAB
$388M
$7.83M 0.92%
1,000,000
+200,000
+25% +$1.57M
IMVT icon
33
Immunovant
IMVT
$2.56B
$7.43M 0.87%
300,000
-800,000
-73% -$19.8M
GERN icon
34
Geron
GERN
$893M
$7.08M 0.83%
+2,000,000
New +$7.08M
ACRS icon
35
Aclaris Therapeutics
ACRS
$209M
$5.51M 0.64%
+2,222,222
New +$5.51M
TRVI icon
36
Trevi Therapeutics
TRVI
$883M
$5.15M 0.6%
1,250,000
-1,500,000
-55% -$6.18M
ATXS icon
37
Astria Therapeutics
ATXS
$349M
$4.47M 0.52%
500,000
– –
UNCY icon
38
Unicycive Therapeutics
UNCY
$74M
$4.03M 0.47%
5,078,927
– –
JBIO
39
Jade Biosciences, Inc. Common Stock
JBIO
$258M
$3.71M 0.43%
+1,400,000
New +$3.71M
RAPP
40
Rapport Therapeutics
RAPP
$643M
$3.71M 0.43%
208,910
– –
ATYR
41
aTyr Pharma
ATYR
$527M
$3.62M 0.42%
1,000,000
-1,000,000
-50% -$3.62M
ALLK
42
DELISTED
Allakos
ALLK
$3.51M 0.41%
2,900,000
– –
ELVN icon
43
Enliven Therapeutics
ELVN
$1.2B
$3.15M 0.37%
140,000
-355,000
-72% -$7.99M
SEPN
44
Septerna, Inc. Common Stock
SEPN
$539M
$3.07M 0.36%
+134,202
New +$3.07M
ARTV
45
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$76.7M
$1.46M 0.17%
145,089
– –
CBIO
46
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
$1.34M 0.16%
+5,400,000
New +$1.34M
NUVB.WS icon
47
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$68M
$15.3K ﹤0.01%
+66,666
New +$15.3K
BCYC
48
Bicycle Therapeutics
BCYC
$511M
– –
-500,000
Closed -$11.3M
BEAM icon
49
Beam Therapeutics
BEAM
$1.66B
– –
-500,000
Closed -$12.3M
CLDX icon
50
Celldex Therapeutics
CLDX
$1.47B
– –
-900,000
Closed -$30.6M
1
2
3